Revenue up 35.9%, domestic volumes up 34%, SUVs up 35% — but commodity inflation and a settlement cycle change crushed EBITDA by 18.7% versus estimates
Maruti Suzuki’s Q1FY27 was a tale of two numbers. The volume and revenue story was genuinely impressive — 29.3% overall volume growth, domestic up 34%, SUVs up 35%, revenue beating estimates. The margin story was the opposite — EBITDA missed Nirmal Bang’s estimate by 18.7% and consensus by 17.9%, with EBITDA margin collapsing to 8.2% from 11.6% a year ago.
The divergence between a strong top line and a painful operating line is the central question investors need to resolve before deciding what to do with the stock. Nirmal Bang maintains BUY with a target of Rs 16,580, based on 25.5x June 2028 EPS — arguing that the margin pain is largely temporary and that the volume trajectory is what endures.
Broad-Based and Better
Standalone revenue grew 35.9% year-on-year to Rs 524.6 billion — beating estimates by 1.4% and consensus by 0.4%. The growth was not concentrated in one segment. Domestic volumes grew 34.1% year-on-year. Exports grew 28.6%. SUVs — the highest-value and fastest-growing portion of the portfolio — grew 35.2%. The breadth of the volume beat is important because it reflects genuine demand strength across multiple customer segments and price points rather than a single model driving a temporary spike.
Dealer inventory remained lean at approximately 13 days — a level that signals strong retail offtake rather than channel stuffing. The order book stood at approximately 130,000 units excluding the Brezza, and management reiterated approximately 10% FY27 volume growth guidance despite supply constraints. July dispatches confirmed the momentum continues — total passenger vehicle volumes rose 33.5% year-on-year to 237,501 units.
“Bookings, walk-ins, and enquiry levels continue to support the demand pipeline,” as the broader industry pattern suggests — and Maruti, with its unmatched distribution network and brand reach, is capturing a disproportionate share of the recovery.
The Margin Miss
EBITDA fell 6.7% year-on-year to Rs 43.1 billion, with EBITDA margin at 8.2% — 375 basis points below the year-ago level. Gross margin contracted 604 basis points year-on-year to 23.1%. The drivers are specific and worth understanding carefully. Commodity inflation hit margins directly.
Adverse forex movements — the rupee depreciation against the yen and dollar for imported components — added pressure. And a technical but important factor: Maruti temporarily shifted the settlement cycle for key commodities from quarterly to monthly, accelerating cost pass-through into Q1 that would otherwise have been spread across quarters. This timing change contributed approximately 110 basis points to the gross margin compression in Q1 alone.
“The company temporarily shifted the settlement cycle for key commodities from quarterly to monthly, accelerating cost pass-through in Q1, with the impact expected to unwind gradually over Q2-Q3FY27,” Nirmal Bang notes
GST Rationalisation
One of the less-discussed but potentially important demand drivers for Maruti is the GST rationalisation that has improved affordability for entry-level vehicles. Maruti dominates India’s entry-level passenger vehicle market — Alto, WagonR, S-Presso — a segment that had been under pressure for several years as consumers delayed purchases and aspired toward SUVs. GST relief on these vehicles improves the total cost of ownership and could accelerate a recovery in the entry segment that adds volume at the bottom of Maruti’s portfolio while the SUV ramp continues at the top.
“Expected recovery in the entry segment following GST rationalization” is specifically cited by Nirmal Bang as one of the structural drivers supporting the BUY — and it is a catalyst that is independent of commodity cycles or global freight dynamics.
Capacity Expansion
Maruti’s capacity expansion programme is advancing on schedule. The second Kharkhoda line and the fourth Hansalpur line — 250,000 units each — have been commissioned, taking total installed capacity to approximately 2.9 million units. This matters because capacity has been the binding constraint on Maruti’s volume growth through FY27, with management itself acknowledging supply constraints in guidance. As the new lines ramp up, the volume ceiling lifts — and with an order book and demand pipeline that management describes as robust, the incremental capacity has a clear home.
The multi-powertrain strategy adds further dimensions to the growth story. ICE, CNG, hybrid and EV platforms across the portfolio mean Maruti is not exposed to a binary bet on any single technology. The export footprint across 100+ markets provides a global volume buffer against domestic cycle softness. “Expanding export footprint across 100+ markets and ongoing capacity expansion” are the two structural enablers that Nirmal Bang expects will allow MSIL to outpace industry volume growth in FY27.
West Asia-related freight costs remain elevated — shipping rates through affected routes have increased, adding to imported component costs. Commodity inflation, while partially offset by pricing actions and a 1.75% price hike, has not fully normalised. “Near-term headwinds from West Asia-related freight and commodity inflation persist,” the report acknowledges — but frames these as outweighed by the structural drivers rather than permanent impairments to the business model.
Scorecard
| Metric | Value |
|---|---|
| Current Market Price | ~Rs 14,230 (implied) |
| Target Price | Rs 16,580 (raised) |
| Upside | ~16% |
| Rating | BUY |
| Valuation | 25.5x Jun-28E EPS |
| Q1FY27 Revenue | Rs 524.6 billion (+35.9% YoY) |
| Q1FY27 EBITDA Margin | 8.2% (-375bps YoY) |
| Volume Growth Q1FY27 | 29.3% YoY |
| Domestic Volume Growth | 34.1% YoY |
| SUV Volume Growth | 35.2% YoY |
| FY27E Volume Growth | ~14% |
| FY28E EBITDA Margin | 12.4% |
| Installed Capacity | ~2.9mn units |
Nirmal Bang maintains FY27 and FY28 estimates unchanged — a signal that the Q1 margin miss, while severe in the quarter, does not alter the full-year trajectory. The FY28 EBITDA margin of 12.4% — recovering to above FY26 levels — is the earnings inflection that the 25.5x multiple is underwriting.